Treatment of Hypercortisolism in People with Difficult-to-Control Type 2 Diabetes—Final Results of the CATALYST Trial

Symposium agenda

• Expanding Evidence for the Impact of Hypercortisolism on People with Difficult-to-Control Type 2 Diabetes
  Ralph A. DeFronzo, MD
• Design of the CATALYST Trial and Prevalence Results
  Vanita R. Aroda, MD
• Final Results of the CATALYST Trial
  Vivian Fonseca, MD
• Implications—A New Paradigm for Understanding and Treating Type 2 Diabetes
  John B. Buse, MD, PhD

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.

DeFronzo Presentation Aroda Presentation Fonseca Presentation Buse Presentation

Download Manuscript